학술논문

EARLY CLINICAL RESULTS AND PRECLINICAL VALIDATION OF THE O-GLCNACASE (OGA) INHIBITOR MK-8719 AS A NOVEL THERAPEUTIC FOR THE TREATMENT OF TAUOPATHIES.
Document Type
Article
Source
Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jul2016 Supplement, Vol. 12, pP261-P261, 1p
Subject
Language
ISSN
15525260